Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6595986rdf:typepubmed:Citationlld:pubmed
pubmed-article:6595986lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6595986lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:6595986lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:6595986lifeskim:mentionsumls-concept:C0006020lld:lifeskim
pubmed-article:6595986pubmed:dateCreated1985-1-31lld:pubmed
pubmed-article:6595986pubmed:abstractTextUsing an in vitro technique it has been demonstrated that water-emulsifying and hydrophobic ointments containing boric acid liberate only minute amounts (1-6%) within 24 h compared with the nearly total liberation from a jelly. When an amount of boric acid containing ointment is swallowed, the absorption is only slightly delayed compared with a similar intake when dissolved in water, and in both cases nearly total excretion is found in the urine within 96 h. The halflife (t 1/2 beta) is 21 h (mean, 7 adult men). The pharmacokinetics rule out the risk of cumulative poisoning with topical preparations containing low amounts of boric acid. The use of water-emulsifying ointments containing up to 3% boric acid should be safe, even for repeated daily use in the napkin region.lld:pubmed
pubmed-article:6595986pubmed:languageenglld:pubmed
pubmed-article:6595986pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6595986pubmed:citationSubsetIMlld:pubmed
pubmed-article:6595986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6595986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6595986pubmed:statusMEDLINElld:pubmed
pubmed-article:6595986pubmed:issn0171-9750lld:pubmed
pubmed-article:6595986pubmed:authorpubmed-author:JansenJ AJAlld:pubmed
pubmed-article:6595986pubmed:authorpubmed-author:AggerbeckBBlld:pubmed
pubmed-article:6595986pubmed:authorpubmed-author:SchouJ SJSlld:pubmed
pubmed-article:6595986pubmed:issnTypePrintlld:pubmed
pubmed-article:6595986pubmed:volume7lld:pubmed
pubmed-article:6595986pubmed:ownerNLMlld:pubmed
pubmed-article:6595986pubmed:authorsCompleteYlld:pubmed
pubmed-article:6595986pubmed:pagination232-5lld:pubmed
pubmed-article:6595986pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6595986pubmed:meshHeadingpubmed-meshheading:6595986-...lld:pubmed
pubmed-article:6595986pubmed:meshHeadingpubmed-meshheading:6595986-...lld:pubmed
pubmed-article:6595986pubmed:meshHeadingpubmed-meshheading:6595986-...lld:pubmed
pubmed-article:6595986pubmed:year1984lld:pubmed
pubmed-article:6595986pubmed:articleTitleHuman pharmacokinetics and safety of boric acid.lld:pubmed
pubmed-article:6595986pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6595986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6595986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6595986lld:pubmed